Novel cAMP signalling paradigms: therapeutic implications for airway disease
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Since its discovery over 50 years ago, cAMP has been the archetypal second messenger introducing students to the concept of cell signalling at the simplest level. As explored in this review, however, there are many more facets to cAMP signalling than the path from Gs‐coupled receptor to adenylyl cyclase (AC) to cAMP to PKA to biological effect. After a brief description of this canonical cAMP signalling pathway, a snapshot is provided of the novel paradigms of cAMP signalling. As in the airway the cAMP pathway relays the major bronchorelaxant signal and as such is the target for frontline therapy for asthma and COPD, particular emphasis is given to airway disease and therapy. Areas discussed include biased agonism, continued signalling following internalization, modulation of cAMP by AC, control of cAMP degradation, cAMP and calcium crosstalk, Epac‐mediated signalling and finally the implications of altered genotypes will be considered. LINKED ARTICLES This article is part of a themed section on Novel cAMP Signalling Paradigms. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2012.166.issue‐2
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
Martin, A. C. L., Willoughby, D., Ciruela, A., Ayling, L.-J., Pagano, M., Wachten, S., Tengholm, A., & Cooper, D. M. F. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.051748 · Cited by 75 · cited 1×
“Intriguingly in HEK293 cells, Martin et al. (2009) observed Stim and Orai to also colocalize with AC8 in lipid rafts, providing further evidence of the interaction between SOCC and cAMP signalling.”
BackgroundBogard, A. S., Xu, C., & Ostrom, R. S. (2011) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.177923 · Cited by 51 · cited 3×
“, overexpressed AC6 in hASM cells and each found cAMP to be elevated versus empty vector controls (Billington et al., 1999; Bogard et al., 2011) and even versus hASM cells individually overexpressing the other key components of the pathway; b2-adrenoceptor and Gsa (Billington et al.”
Background
Cited by
The Concise Guide to PHARMACOLOGY 2013/14: Enzymes
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12451 · Cited by 425
β 2 -Agonist Therapy in Lung Disease
Cazzola, M., Page, C. P., Rogliani, P., & Matera, M. G. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201209-1739pp · Cited by 262
Panossian, A., Seo, E.-J., & Efferth, T. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.09.204 · Cited by 127
Zhu, T., Wu, X.-L., Zhang, W., & Xiao, M. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160920195 · Cited by 106
Motoyoshi, S., Yamamoto, Y., Munesue, S., Igawa, H., Harashima, A., Saito, H., Han, D., Watanabe, T., Sato, H., & Yamamoto, H. (2014) · Biochemical Journal · doi:10.1042/bj20140084 · Cited by 20
Metadata
- Authors
- Billington, C. K., & Hall, I. P.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2012-04-13
- Volume
- 166
- Issue
- 2
- Pages
- 401-410
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1557078354
- Cited by
- 50
- References
- 3
- FWCI
- 2.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Novel cAMP signalling paradigms: therapeutic implications for airway disease. https://app.cochat.ai/papers/10.1111/j.1476-5381.2011.01719.x
- The paper
- Billington, C. K., & Hall, I. P. (2012). Novel cAMP signalling paradigms: therapeutic implications for airway disease. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2011.01719.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.